Obesity

You can also try the following methods, and our professionals will serve you Customized Consultation

Cat. No.	Product Name	Field of Application
DC7495	SB-334867 HCl Featured	SB-334867 is a selective non-peptide orexin OX1 receptor antagonist with a pKb value of 7.2. More description
DC7109	Otenabant (CP-945598 free base) Featured	Otenabant (CP945598) is a recently discovered selective, high affinity, competitive CB1 receptor antagonist with Ki of 0.7 nM. More description
DC1076	Otenabant(CP945598.HCl) Featured	CP-945598 HCl is a potent and selective cannabinoid type 1 receptor antagonist with Ki of 0.7 nM. More description
DC8419	SB-334867 Featured	SB-334867 is a selective orexin-1 (OX1) receptor antagonist. More description
DC12255	MLN-4760 Featured	MLN-4760 is a potent and selective human ACE2 inhibitor (IC50, 0.44 nM), with excellent selectivity (>5000-fold) versus related enzymes including human testicular ACE (IC50, >100 μM) and bovine carboxypeptidase A (CPDA; IC50, 27 μM). More description
DC4158	Tranabant (MK-0364)	Taranabant is a highly selective cannabinoid-1 (CB1) receptor inverse agonist. More description
DC9414	DGAT-1 inhibitor 2	DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. More description
DC8160	ZGN-440(Beloranib)	Beloranib is being studied as a first-in-class obesity therapy that demonstrates a unique mechanism of action through methionine aminopeptidase 2 (MetAP2 ) inhibition. More description